CB2 Receptor Involvement in the Treatment of Substance Use Disorders
The pharmacological modulation of the cannabinoid receptor 2 (CB2r) has emerged as a promising potential therapeutic option in addiction. The purpose of this review was to determine the functional involvement of CB2r in the effects produced by drugs of abuse at the central nervous system (CNS) level...
Guardado en:
Autores principales: | Francisco Navarrete, María S. García-Gutiérrez, Ani Gasparyan, Daniela Navarro, Jorge Manzanares |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a2301fb7cdd4bb6b91e343bb7702204 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bipolar Disorder and Comorbid Use of Illicit Substances
por: Ulrich W. Preuss, et al.
Publicado: (2021) -
Bioethics, Autonomy, and Self-Determination in Patients Admitted to a Teaching Hospital for Treatment of Substance Use Disorder
por: Franca-Garcia,Lucas, et al.
Publicado: (2017) -
Prevalencia de trastornos psiquiátricos por uso de alcohol y otras sustancias en hombres y mujeres hospitalizados en medicina interna de un hospital de Santiago de Chile
por: Hernández G,Guillermo, et al.
Publicado: (2002) -
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
por: Amer H. Tarawneh, et al.
Publicado: (2022) -
Astroglial CB1 Cannabinoid Receptors Mediate CP 55,940-Induced Conditioned Place Aversion Through Cyclooxygenase-2 Signaling in Mice
por: Jin Cong, et al.
Publicado: (2021)